#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prostate cancer Skin angiosarcoma Multifocal motor neuropathy Exudative retinopathy Metachromatic leukodystrophy Mitochondrial DNA depletion ABO haemolytic disease of newborn Andersen-Tawil syndrome Oesophageal squamous cell carcinoma stage III Muscular dystrophy Angelman's syndrome Pleomorphic liposarcoma Cholestatic pruritus Immunodeficiency congenital Chronic granulomatous disease More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory Niemann-Pick disease – Treatment Ewing’s sarcoma recurrent – Trials in Disease Haemophagocytic lymphohistiocytosis – Diagnostics Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Leiomyosarcoma metastatic Synovial sarcoma recurrent – Treatment Mantle cell lymphoma stage III – Basic Information Langerhans’ cell histiocytosis Erdheim-Chester disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Oregovomab Pf-06480605 Tobramycin Colestyramine Gs-4182 BRENSOCATIB Empagliflozin Doxycycline Lolium Perenne Peginterferon Alfa-2A Radium Ra 223 Dichloride Niraparib MAGNESIUM ACETATE TETRAHYDRATE Inupadenant Nazartinib VX-993 Elafibranor Nivolumab Dapagliflozin ORG-129 More therapies…

    Learn about Your Condition

    Exudative retinopathy Malignant mast cell neoplasm Hepatic neoplasm Polymyalgia rheumatica Plasma cell leukaemia Bronchitis Spondylolisthesis Hypochondroplasia Muscle strain Bartonellosis Biliary cancer metastatic Asthma Leukaemia Hypoxia Electrocorticogram More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Comparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Montelukast
    Spain

  • Study on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma

    Not recruiting

    2 1
    Investigated Drugs:
    • GSK5784283
    Bulgaria Czechia Germany Romania Spain

  • Study on the Effectiveness and Safety of Benralizumab with Budesonide and Formoterol in Patients with Eosinophilic Asthma Uncontrolled by Standard Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Benralizumab
    • Budesonide
    Bulgaria France Germany Ireland Italy Norway +1

  • Study comparing absorption of inhaled Tanimilast (CHF 6001) in adolescent and adult asthma patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tanimilast
    Bulgaria

  • Study on the Effects of Lunsekimig (SAR443765) in Adults with High-Risk Asthma Not Eligible for Biologic Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark France Germany Hungary Italy +4

  • Study of Dupilumab’s Effect on Airway Mucus in Adults with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dupilumab
    Austria
Previous Page
1 … 5 6 7 8 9 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!